Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
The Annals of Pharmacotherapy|November 4, 2004
Duloxetine: a dual reuptake inhibitorSara E Dugan, Matthew A FullerThe Mental Health Clinician|December 8, 2025
Safety considerations for patients using cannabisSara E DuganPsychiatric Services (Washington, D.C.)|June 25, 2020
Informed Consent: A Policy Prescription for Communicating Benefit and Risk in State Medical Marijuana ProgramsErik Messamore, Sara E DuganClinical Therapeutics|April 28, 2009
Varenicline: a first-line treatment option for smoking cessationGina Daubney Garrison, Sara E DuganThe Annals of Pharmacotherapy|November 4, 2004
Long-acting injectable risperidoneMegan J Ehret, Matthew A FullerThe Annals of Pharmacotherapy|July 6, 2012
Dalfampridine: a medication to improve walking in patients with multiple sclerosisTheodore E Pikoulas, Matthew A FullerJournal of Pharmacy Practice|December 14, 2011
Asenapine: a new antipsychotic optionJessica M Henry, Matthew A FullerNeuropsychiatric Disease and Treatment|May 5, 2009
Risperidone in the treatment of bipolar maniaMartha Sajatovic, Madhusoodanan Subramoniam, Matthew A FullerThe Annals of Pharmacotherapy|December 29, 2005
Catatonic schizophrenia and the use of memantineStacey S Carpenter, A Daniel Hatchett, Matthew A FullerThe Mental Health Clinician|May 25, 2019
Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophreniaRobert J Willborn, Colleen P Hall, Matthew A FullerPageof 3